Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SZRD1 pseudogene 1 (SZRD1P1) is classified as a pseudogene corresponding to the parent gene SUZ RNA Binding Domain Containing 1 (SZRD1)[5]. There is no published evidence that SZRD1P1 encodes a functional protein or has a confirmed biological activity as a therapeutic target. SZRD1 pseudogene 1 (SZRD1P1) is annotated as a **pseudogene**, meaning it is a genomic DNA sequence that resembles the functional SZRD1 gene but is generally non-coding and presumed to lack protein-coding capacity[5]. SZRD1P1 does not belong to a recognized protein family such as receptors, enzymes, channels, or other molecular target classes. There are no reports on its biological function, its involvement in disease, or its relevance as a pharmacological or therapeutic target. The parent gene, SZRD1, is a protein-coding gene with roles in cell cycle regulation and potential tumor suppressor function[1][2][3], but SZRD1P1 itself is not reported to have therapeutic or diagnostic value. If more evidence emerges regarding pseudogene regulatory roles (such as acting as competitive endogenous RNAs[4]), this could affect future classification, but currently, no such data exist for SZRD1P1 specifically. SZRD1P1 is **not a known or validated therapeutic target**, reflects a pseudogene annotation, and is considered incorrect for most target-oriented drug discovery contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SZRD1 pseudogene 1 (SZRD1P1).